David Challen, Story Landis, Paul Ray, Dave Bengston, John Dill, Timothy Estep, Jay Gershen, Terry Knapp, Caroline Kovac, Ned Scheetz, Richard Williams

Aug 08, 2003

Premium

David Challen has been appointed to the board of directors of Amersham PLC, Amersham Biosciences’ UK-based parent company. Challen is currently vice-chairman of Citigroup’s European Investment Bank. Prior to this, Challan was co-chairman at Schroder Salomon Smith Barney, after Schroder’s investment banking business — where he was chairman — merged with Salomon Smith Barney.

Story Landis has been appointed director of the National Institute of Neurological Disorders and Stroke.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Main menu